Increase in adoption of smartphones and tablets coupled with healthcare apps, growth in need to control healthcare cost, and rise in incidence of chronic diseases drive the growth of the U.S. digital therapeutics market. However, lack of awareness regarding digital therapeutics and patient data privacy concerns restrain the market growth. The impact of the driving factors is expected to surpass that of the restraints. Hence, the market is projected to grow at a CAGR of 19.2% from 2020 to 2027. On the contrary, favorable laws and regulations for digital health technology and increase in investments in digital therapeutics are anticipated to offer significant growth opportunities for the market players in the future.
The U.S. digital therapeutics market is segmented into application, product type, sales channel, and region. By application, it is divided into diabetes, obesity, cardio vascular diseases (CVD), central nervous system (CNS) disease, respiratory diseases, smoking cessation, gastrointestinal disorders, and others. By product, it is classified into software and devices. Further, on the basis of sales channel, it is bifurcated into business-to-business (B2B) and business-to-consumers (B2C). Furthermore, business-to-business (B2B) is categorized into employer & payer, healthcare providers, and others. By business-to-consumers, it is classified into patients and caregivers.
Key Benefits for Stakeholders
- This report provides a detailed quantitative analysis of the current U.S. digital therapeutics market trends and future estimations from 2020 to 2027, which assists to identify the prevailing market opportunities.
- An in-depth analysis of various regions is anticipated to provide a detailed understanding of the current trends to enable stakeholders to formulate country-specific plans.
- A comprehensive analysis of the factors that drive and restrain the growth of the U.S. digital therapeutics market is provided.
- An extensive analysis of various regions provides insights that allow companies to strategically plan their business moves.
- Cardiovascular Disease (CVD)
- Central Nervous System (CNS) Disease
- Respiratory Disease
- Smoking Cessation
- Gastrointestinal Disorder (GID)
- Business-to-Business (B2B)
- Employer and Payer
- Healthcare Provider
- Business-to-Consumer (B2C)
- 2MORROW, Inc.
- Fitbit, Inc. (Twine Health, Inc.)
- Livongo Health, Inc.
- Medtronic Plc.
- Omada Health, Inc.
- Pear Therapeutics, Inc.
- Proteus Digital Health, Inc.
- Resmed, Inc. (Propeller Health)
- Voluntis, Inc.
- Welldoc, Inc.
- Canary Health Inc.
- Mango Health Inc.
- Noom, Inc.
- Dthera Sciences
1.1. Report Description
1.2. Key Benefits for Stakeholders
1.3. Key Market Segments
1.4. Research Methodology
1.4.1. Secondary Research
1.4.2. Primary Research
1.4.3. Analyst Tools & Models
Chapter 2: Executive Summary
2.1. Cxo Perspective
Chapter 3: Market Overview
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Top Player Positioning, 2019
3.4. Porter’S Five Forces Analysis
3.5. Market Dynamics
188.8.131.52. Increase in Adoption of Smartphones, Tablets, and Smart Wearables, Coupled With Healthcare Apps
184.108.40.206. Urge in Need to Control Healthcare Costs
220.127.116.11. Rise in Prevalence of Chronic Diseases
18.104.22.168. Growth in Adoption of Advanced Technologies and Tech-Driven Healthcare Products & Applications
22.214.171.124. Lack of Reimbursement Policies for Digital Therapeutics
126.96.36.199. Patient Data Privacy Concerns
188.8.131.52. Favorable Laws and Regulations for Digital Health Technology
184.108.40.206. Increase in Investments in Digital Therapeutics
3.6. Impact Analysis of Covid-19 on the U.S. Digital Therapeutics Market
Chapter 4: Digital Therapeutics Market, by Application
4.1.1. Market Size and Forecast
4.2.1. Key Market Trends and Growth Opportunities
4.2.2. Market Size and Forecast
4.3.1. Key Market Trends and Growth Opportunities
4.3.2. Market Size and Forecast
4.4. Cardiovascular Diseases
4.4.1. Key Market Trends and Growth Opportunities
4.4.2. Market Size and Forecast
4.5. Central Nervous System (Cns) Diseases
4.5.1. Key Market Trends and Growth Opportunities
4.5.2. Market Size and Forecast
4.6. Gastrointestinal Disorder
4.6.1. Key Market Trends and Growth Opportunities
4.6.2. Market Size and Forecast
4.7. Respiratory Diseases
4.7.1. Key Market Trends and Growth Opportunities
4.7.2. Market Size and Forecast
4.8. Smoking Cessation
4.8.1. Key Market Trends and Growth Opportunities
4.8.2. Market Size and Forecast
4.9.1. Key Market Trends and Growth Opportunities
4.9.2. Market Size and Forecast
Chapter 5: Digital Therapeutics Market, by Product
5.1.1. Market Size and Forecast
5.2.1. Market Size and Forecast
5.3.1. Market Size and Forecast
Chapter 6: Digital Therapeutics Market, by Sales Channel
6.1.1. Market Size and Forecast
6.2. Business-To-Business (B2B)
6.2.1. Market Size and Forecast, by Type
6.2.2. Employer and Payer
220.127.116.11. Market Size and Forecast
6.2.3. Healthcare Providers
18.104.22.168. Market Size and Forecast
22.214.171.124. Market Size and Forecast
6.3.1. Market Size and Forecast, by Type
126.96.36.199. Market Size and Forecast
188.8.131.52. Market Size and Forecast
Chapter 7: Company Profiles
7.1.1. Company Overview
7.1.2. Company Snapshot
7.1.3. Operating Business Segments
7.1.4. Product Portfolio
7.1.5. Key Strategic Moves and Developments
7.2. Fitbit, Inc. (Twine Health, Inc.)
7.2.1. Company Overview
7.2.2. Company Snapshot
7.2.3. Product Portfolio
7.2.4. Business Performance
7.2.5. Key Strategic Moves and Developments
7.3. Livongo Health, Inc.
7.3.1. Company Overview
7.3.2. Company Snapshot
7.3.3. Product Portfolio
7.3.4. Business Performance
7.3.5. Key Strategic Moves and Developments
7.4. Medtronic plc.
7.4.1. Company Overview
7.4.2. Company Snapshot
7.4.3. Operating Business Segments
7.4.4. Product Portfolio
7.4.5. Business Performance
7.4.6. Key Strategic Moves and Developments
7.5. Pear Therapeutics, Inc.
7.5.1. Company Overview
7.5.2. Company Snapshot
7.5.3. Operating Business Segments
7.5.4. Product Portfolio
7.5.5. Key Strategic Moves and Developments
7.6. Omada Health, Inc.
7.6.1. Company Overview
7.6.2. Company Snapshot
7.6.3. Operating Business Segments
7.6.4. Product Portfolio
7.6.5. Key Strategic Moves and Developments
7.7. Proteus Digital Health, Inc.
7.7.1. Company Overview
7.7.2. Company Snapshot
7.7.3. Operating Business Segments
7.7.4. Product Portfolio
7.7.5. Key Strategic Moves and Developments
7.8. Resmed, Inc. (Propeller Health)
7.8.1. Company Overview
7.8.2. Company Snapshot
7.8.3. Operating Business Segments
7.8.4. Product Portfolio
7.8.5. Business Performance
7.8.6. Key Strategic Moves and Developments
7.9. Voluntis, Inc.
7.9.1. Company Overview
7.9.2. Company Snapshot
7.9.3. Operating Business Segments
7.9.4. Product Portfolio
7.9.5. Business Performance
7.9.6. Key Strategic Moves and Developments
7.10. Welldoc, Inc.
7.10.1. Company Overview
7.10.2. Company Snapshot
7.10.3. Operating Business Segments
7.10.4. Product Portfolio
7.10.5. Key Strategic Moves and Developments
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.